Re: Wolfe et al. Do rheumatology cost-effectiveness analyses make sense?

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15103038)

Published in Rheumatology (Oxford) on May 01, 2004

Authors

A Brennan, N Bansback

Articles cited by this

Do rheumatology cost-effectiveness analyses make sense? Rheumatology (Oxford) (2003) 1.46

Articles by these authors

Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess (2007) 3.40

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. Rheumatology (Oxford) (2003) 2.41

Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron (1995) 2.02

Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ (2010) 2.00

Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev (2009) 1.78

Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax (2005) 1.78

Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry. Rheumatology (Oxford) (2007) 1.77

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J Exp Med (1983) 1.62

Brain responses to changes in bladder volume and urge to void in healthy men. Brain (2001) 1.50

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol (1994) 1.35

Economic evaluation of systemic therapies for moderate to severe psoriasis. Br J Dermatol (2008) 1.35

Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med (2007) 1.34

Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci (1999) 1.25

P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol Cell Neurosci (1997) 1.24

The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron (1994) 1.24

The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. Rheumatology (Oxford) (2007) 1.19

Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden. Ann Rheum Dis (2004) 1.09

Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technol Assess (2013) 1.07

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health Technol Assess (2012) 1.07

Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study. Neuropsychiatry Neuropsychol Behav Neurol (2001) 1.06

Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med (2014) 1.02

Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation. Eur J Neurosci (2001) 1.00

The role of modelling in prioritising and planning clinical trials. Health Technol Assess (2003) 1.00

Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet (1993) 0.96

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Health Technol Assess (2008) 0.94

Determination of the burden of hepatitis C virus infection in Ireland. Epidemiol Infect (2011) 0.92

Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines. Eur J Immunol (1984) 0.90

Helix-loop-helix proteins in Schwann cells: a study of regulation and subcellular localization of Ids, REB, and E12/47 during embryonic and postnatal development. J Neurosci Res (1997) 0.89

Manual therapy for osteoarthritis of the hip or knee - a systematic review. Man Ther (2010) 0.89

The cost-effectiveness of sibutramine in non-diabetic obese patients: evidence from four Western countries. Obes Rev (2007) 0.88

Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Rheumatology (Oxford) (2006) 0.87

In early development of the rat mRNA for the major myelin protein P(0) is expressed in nonsensory areas of the embryonic inner ear, notochord, enteric nervous system, and olfactory ensheathing cells. Dev Dyn (2001) 0.87

Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology (1989) 0.87

In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1992) 0.86

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. Health Technol Assess (2001) 0.86

A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Health Technol Assess (2001) 0.85

Genetic structures associated with spread of the type Ia trimethoprim-resistant dihydrofolate reductase gene amongst Escherichia coli strains isolated in the Nottingham area of the United Kingdom. J Antimicrob Chemother (1994) 0.85

Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels. J Thromb Haemost (2014) 0.85

Modulation of myelomonocytic U937 cells by vitamin D metabolites. Bone Miner (1989) 0.85

Increasing milk solids production across lactation through genetic selection and intensive pasture-based feed system. J Dairy Sci (2010) 0.84

Regulation of genes involved in Schwann cell development and differentiation. Prog Brain Res (2001) 0.83

A comparison of three brands of polysulfone membranes. J Am Soc Nephrol (1996) 0.83

A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK. Int J Cardiol (2005) 0.83

Is it feasible to plan secondary care services for coronary heart disease rationally? A quantified modelling approach for a UK Health Authority. J Epidemiol Community Health (2001) 0.83

Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure. Cell Immunol (1984) 0.82

1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology (1991) 0.82

Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model. Diabet Med (2014) 0.81

Development and differentiation of Schwann cells. Rev Neurol (Paris) (1996) 0.81

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction. Int J Cardiol (2009) 0.81

Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol (1997) 0.80

Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods. Appl Health Econ Health Policy (2014) 0.79

Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess (2006) 0.79

The effect of three dimensional collagen type I preparation on the structural organization of guinea pig enteric ganglia in culture. Exp Cell Res (1993) 0.79

Anarchic hand syndrome following resection of a frontal lobe tumor. Neurocase (2012) 0.79

Time-dependent stabilisation of the TSH-TSH receptor complex. FEBS Lett (1980) 0.79

MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease. Lancet (1993) 0.79

The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ (2005) 0.78

An ecological perspective on Brucella abortus in the western United States. Rev Sci Tech (2013) 0.78

The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. Diabet Med (2013) 0.78

Fibroblast growth factors and insulin growth factors combine to promote survival of rat Schwann cell precursors without induction of DNA synthesis. Eur J Neurosci (1995) 0.78

Dry matter intake and feed efficiency profiles of 3 genotypes of Holstein-Friesian within pasture-based systems of milk production. J Dairy Sci (2010) 0.77

Activation-induced cellular accumulation of histamine in immature but not mature murine mast cells. Cell Mol Life Sci (2008) 0.77

The incidence of childhood type 1 diabetes in Ireland and the National Childhood Diabetes Register. Ir Med J (2014) 0.77

Sex differences in lateralization in the domestic chick. Neuropsychologia (1984) 0.77

Mononuclear phagocytes and HSV-1 infection: increased permissivity in differentiated U937 cells is mediated by post-transcriptional regulation of viral immediate-early gene expression. J Leukoc Biol (1990) 0.76

The NICE reappraisal of biologics in 2005: what rheumatologists need to know. Rheumatology (Oxford) (2004) 0.76

The comparative role of 1,25-dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line. Immunology (1992) 0.76

Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials". Eur J Health Econ (2003) 0.75

The effect of stocking rate and calving date on reproductive performance, body state, and metabolic and health parameters of Holstein-Friesian dairy cows. J Dairy Sci (2012) 0.75

Shedding of surface proteins by porcine thyroid cells. J Endocrinol (1980) 0.75

Diabetes mellitus: biomedical health education/promotion approach. Br J Nurs (1996) 0.75

Obstetric anaesthesia for Asian patients. Int J Obstet Anesth (1999) 0.75

Successful immunosuppression of renal allograft recipients with alternate day steroid therapy. Clin Nephrol (1978) 0.75

Maturity Onset Diabetes in the Young (MODY) type 3. Ir Med J (2005) 0.75

The enigma of puerperal psychosis. Nurs Stand (1991) 0.75

Analysing mandatory continuing education. Nurs Stand (1992) 0.75

Problems in the interpretation of serological results of hepatitis B testing during an incident of hepatitis B virus reactivation in a dialysis unit. Infect Control Hosp Epidemiol (2007) 0.75

Clinicians' conundrum. Nurs Times (1989) 0.75

Clinical assessment. N Z Nurs J (1975) 0.75

Hepatitis B reactivation in an Irish dialysis unit, 2005. Euro Surveill (2007) 0.75

Increase in VTEC cases in the south of Ireland: link to private wells? Euro Surveill (2008) 0.75

Preoperative play cart. ONA J (1978) 0.75

Turnover of the thyroid cell surface [proceedings]. J Endocrinol (1979) 0.75

Thyrotrophin receptors in porcine thyroid membranes, detergent-solubilized thyroid membranes and isolated thyroid cells [proceedings]. J Endocrinol (1979) 0.75

Sharply timed and lateralised events at time of establishment of long term memory. Physiol Behav (1985) 0.75

Perceptions of pain: a nursing study. Qld Nurse (1988) 0.75

Successful treatment of severe abulia with co-beneldopa. NeuroRehabilitation (2011) 0.75

Preceptorship: is it a workable concept? Nurs Stand (1993) 0.75

Triaging patients with serious head injury: results of a simulation evaluating strategies to bypass hospitals without neurosurgical facilities. Injury (2001) 0.75

Medicare reimbursement: a hot topic for nurse practitioners. Mich Nurse (2001) 0.75

Renal transplantation. Overall patient and graft success at State University of New York Upstate Medical Center. N Y State J Med (1978) 0.75

Theory and practice correlation. N Z Nurs J (1976) 0.75

Caring for children during procedures: a review of the literature. Pediatr Nurs (1995) 0.75

Modelling the cost-effectiveness and capacity impact of changes to colposcopy referral guidelines for women with mild dyskaryosis in the UK Cervical Screening Programme. BJOG (2008) 0.75

Identification of transcriptionally regulated mRNAs from mouse Schwann cell precursors using modified RNA fingerprinting methods. J Neurosci Res (1997) 0.75

Orthopaedic workload of county Mayo. Ir Med J (2001) 0.75